Clinical Trials Directory

Trials / Completed

CompletedNCT01773902

Protein for Premies

High Versus Standard Dose Protein for Very Preterm Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
7 Days
Healthy volunteers
Not accepted

Summary

Although expressed breast milk is considered the optimal nutritional source for preterm infants, the macronutrient content is insufficient to enable optimal growth during neonatal intensive care. Optimal dose and optimal mode of administration (standardized or individualized) of enteral protein supplementation to very preterm infants have not been established. This study aims to compare the effects on weight gain of different modes of enteral protein supplementation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh Dose Protein (Individualized)Protein supplementation according to breast milk content aiming for 4.5g/kg/d of enteral protein if \<1500g b.w. or 4.0g/kg/d of enteral protein if \>1500g b.w. until 1 week before discharge
DIETARY_SUPPLEMENTHigh Dose Protein (Standardized)Protein supplementation independent of individual breast milk content using a new high-dose-protein breast milk fortifier until 1 week before discharge
DIETARY_SUPPLEMENTStandard Protein SupplementationProtein supplementation independent of individual breast milk content using a standard-dose-protein breast milk fortifier until 1 week before discharge

Timeline

Start date
2012-10-01
Primary completion
2014-12-01
Completion
2016-07-01
First posted
2013-01-23
Last updated
2018-05-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01773902. Inclusion in this directory is not an endorsement.

Protein for Premies (NCT01773902) · Clinical Trials Directory